Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Precigen Stock Is Skyrocketing Today


Shares of Precigen (NASDAQ: PGEN) had skyrocketed by 26.3% as of 11:30 a.m. EDT on Friday. That jump came after Precigen announced that German drugmaker Merck KGaA (OTC: MKKGY) (not to be confused with the U.S.-based Merck) is increasing its stake in the biopharmaceutical company.

Merck KGaA already owned around 11.6% of Precigen. That stake will increase to 14.8% because its wholly owned subsidiary, Ares Trading, is converting a convertible note into stock. Merck KGaA will remain the second-largest shareholder in Precigen.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments